Name | Description | Patent Applicant | Current Assignee | Inventor | Patent Jurisdiction | Patent Number | Date of Patent | ||
|---|---|---|---|---|---|---|---|---|---|
Patent 11384390 was granted and assigned to GeneMind Biosciences Company Limited on July, 2022 by the United States Patent and Trademark Office. | 11384390 | July 12, 2022 | |||||||
Patent 11482304 was granted and assigned to GeneMind Biosciences Company Limited on October, 2022 by the United States Patent and Trademark Office. | 11482304 | October 25, 2022 | |||||||
Patent 11575823 was granted and assigned to GeneMind Biosciences Company Limited on February, 2023 by the United States Patent and Trademark Office. | 11575823 | February 7, 2023 | |||||||
Patent 11368614 was granted and assigned to GeneMind Biosciences Company Limited on June, 2022 by the United States Patent and Trademark Office. | 11368614 | June 21, 2022 | |||||||
Patent 11421272 was granted and assigned to GeneMind Biosciences Company Limited on August, 2022 by the United States Patent and Trademark Office. | 11421272 | August 23, 2022 | |||||||
Patent 11170506 was granted and assigned to GeneMind Biosciences Company Limited on November, 2021 by the United States Patent and Trademark Office. | 11170506 | November 9, 2021 | |||||||
Patent 10467749 was granted and assigned to GeneMind Biosciences Company Limited on November, 2019 by the United States Patent and Trademark Office. | 10467749 | November 5, 2019 | |||||||
Patent 10427154 was granted and assigned to GeneMind Biosciences Company Limited on October, 2019 by the United States Patent and Trademark Office. | 10427154 | October 1, 2019 | |||||||
Patent 11512106 was granted and assigned to GeneMind Biosciences Company Limited on November, 2022 by the United States Patent and Trademark Office. | 11512106 | November 29, 2022 | |||||||
Patent 10981164 was granted and assigned to GeneMind Biosciences Company Limited on April, 2021 by the United States Patent and Trademark Office. | 10981164 | April 20, 2021 | |||||||
Patent 10481094 was granted and assigned to GeneMind Biosciences Company Limited on November, 2019 by the United States Patent and Trademark Office. | 10481094 | November 19, 2019 |